Clinical Trial Update: The FLAVO Trial: Dietary Flavonoids and Cardiovascular Disease Risk Reduction in Postmenopausal Women With Type 2 Diabetes [NA]

View source ↗

Summary

The FLAVO trial, a completed study, evaluated whether dietary flavonoids can reduce cardiovascular disease risk in postmenopausal women with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of East Anglia | Conditions: Cardiovascular Disease, Diabetes | NA | Status: COMPLETED